T1	Participants 115 147	polymyositis and dermatomyositis
T2	Participants 332 387	patients with polymyositis (PM) and dermatomyositis (DM
T3	Participants 408 434	13 patients with PM and DM
T4	Participants 1884 1907	patients with PM and DM
